Global Oral Proteins and Peptides Market Size, Share, Revenue Analysis & Trends Report Segmented by Molecule (Semaglutide, Calcitonin), Drug Class (GLP-1 & CGRP Receptor Agonists), Formulation (Tablets, Capsules, Oral Solutions), Therapeutic Area, End-user & Regional Forecast to 2031

Global Oral Proteins and Peptides Market Segmentation

This report by Medi-Tech Insights provides thesize of the global oral proteins and peptides market at theregional- and country-level from 2024 to 2031. The report further segments the market based on molecule, drug class, formulation, therapeutic area, and end-user.

Market Size & Forecast (2024-2031), By Molecule, USD Million

• Semaglutide
• Calcitonin
• Linaclotide
• Trofinetide
• Voclosporin
• Plecanatide
• Others

Market Size & Forecast (2024-2031), By Drug Class, USD Million

• GLP-1 Receptor Agonists
• CGRP Receptor Agonists
• GC-C Agonists
• GPE
• Others

Market Size & Forecast (2024-2031), By Formulation, >

• Tablets
• Capsules
• Oral Solutions

Market Size & Forecast (2024-2031), By Therapeutic Area, USD Million

• Diabetes
• CNS Disorders
• Gastroenterology
• Genetic Disorders
• Nephrology
• Others

Market Size & Forecast (2024-2031), By End-user, USD Million

• Hospitals & Specialty Clinics
• Home Care Settings
• Long-term Care Facilities
• Others

Market Size & Forecast (2024-2031), By Region, USD Million

• North America
  • US
  • Canada
• Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • Rest of Asia Pacific
• Latin America
• Middle East & Africa